| Trial ID: | L0995 |
| Source ID: | NCT00858182
|
| Associated Drug: |
Pd Solution For Nocturnal Exchanges
|
| Title: |
Study of Safety and Efficacy on New Peritoneal Dialysis Solutions
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
End-Stage Renal Disease
|
| Interventions: |
DRUG: PD solution for nocturnal exchanges|DRUG: PD solution for diurnal exchanges
|
| Outcome Measures: |
Primary: To assess ultrafiltration efficacy of PD solutions containing L-Carnitine and Xylitol, 4 weeks |
|
| Sponsor/Collaborators: |
Sponsor: Iperboreal Pharma Srl
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2009-05
|
| Completion Date: |
2013-01
|
| Results First Posted: |
|
| Last Update Posted: |
2019-06-26
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00858182
|
